Literature DB >> 19822711

Musculoskeletal manifestations of lysosomal storage disorders.

M Aldenhoven1, R J B Sakkers, J Boelens, T J de Koning, N M Wulffraat.   

Abstract

Lysosomal storage disorders (LSDs), a heterogeneous group of inborn metabolic disorders, are far more common than most doctors presume. Although patients with a severe LSD subtype are often readily diagnosed, the more attenuated subtypes are frequently missed or diagnosis is significantly delayed. The presenting manifestations often involve the bones and/or joints and therefore these patients are frequently under specialist care by (paediatric) rheumatologists, receiving inadequate treatment. Since effective disease-specific treatments, including enzyme replacement therapy and stem cell transplantation, have become available for certain LSDs and timely initiation of these treatments is necessary to prevent the development of severe, disabling and irreversible manifestations, early diagnosis has become essential. The challenge is to raise awareness for better recognition of the presenting signs and symptoms of LSDs by all doctors who may encounter these patients, including rheumatologists.

Entities:  

Mesh:

Year:  2009        PMID: 19822711     DOI: 10.1136/ard.2008.095315

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  38 in total

Review 1.  [Lysosomal storage diseases].

Authors:  B Manger
Journal:  Z Rheumatol       Date:  2010-08       Impact factor: 1.372

2.  Growth in patients with mucopolysaccharidosis type III (Sanfilippo disease).

Authors:  J de Ruijter; L Broere; M F Mulder; A T van der Ploeg; M E Rubio-Gozalbo; S B Wortmann; G Visser; F A Wijburg
Journal:  J Inherit Metab Dis       Date:  2013-10-31       Impact factor: 4.982

3.  A Dysmorphometric Analysis to Investigate Facial Phenotypic Signatures as a Foundation for Non-invasive Monitoring of Lysosomal Storage Disorders.

Authors:  Stefanie Kung; Mark Walters; Peter Claes; Jack Goldblatt; Peter Le Souef; Gareth Baynam
Journal:  JIMD Rep       Date:  2012-06-10

4.  β-Glucuronidase, a Regulator of Lyme Arthritis Severity, Modulates Lysosomal Trafficking and MMP-9 Secretion in Response to Inflammatory Stimuli.

Authors:  Kenneth K C Bramwell; Kelton Mock; Ying Ma; John H Weis; Cory Teuscher; Janis J Weis
Journal:  J Immunol       Date:  2015-07-13       Impact factor: 5.422

Review 5.  Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future.

Authors:  Madeleine Taylor; Shaukat Khan; Molly Stapleton; Jianmin Wang; Jing Chen; Robert Wynn; Hiromasa Yabe; Yasutsugu Chinen; Jaap Jan Boelens; Robert W Mason; Francyne Kubaski; Dafne D G Horovitz; Anneliese L Barth; Marta Serafini; Maria Ester Bernardo; Hironori Kobayashi; Kenji E Orii; Yasuyuki Suzuki; Tadao Orii; Shunji Tomatsu
Journal:  Biol Blood Marrow Transplant       Date:  2019-02-14       Impact factor: 5.742

6.  Adverse Effects of Genistein in a Mucopolysaccharidosis Type I Mouse Model.

Authors:  Sandra D K Kingma; Tom Wagemans; Lodewijk IJlst; Jurgen Seppen; Marion J J Gijbels; Frits A Wijburg; Naomi van Vlies
Journal:  JIMD Rep       Date:  2015-04-09

7.  Pitfalls in Diagnosing Neuraminidase Deficiency: Psychosomatics and Normal Sialic Acid Excretion.

Authors:  Imre F Schene; Viera Kalinina Ayuso; Monique de Sain-van der Velden; Koen L I van Gassen; Inge Cuppen; Peter M van Hasselt; Gepke Visser
Journal:  JIMD Rep       Date:  2015-07-05

Review 8.  Hurdles in treating Hurler disease: potential routes to achieve a "real" cure.

Authors:  Brigitte T A van den Broek; Jaap van Doorn; Charlotte V Hegeman; Stefan Nierkens; Caroline A Lindemans; Nanda Verhoeven-Duif; Jaap Jan Boelens; Peter M van Hasselt
Journal:  Blood Adv       Date:  2020-06-23

9.  Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII.

Authors:  Daniel J Rowan; Shunji Tomatsu; Jeffrey H Grubb; Adriana M Montaño; William S Sly
Journal:  J Inherit Metab Dis       Date:  2012-09-13       Impact factor: 4.982

10.  Biomarkers of bone remodeling in children with mucopolysaccharidosis types I, II, and VI.

Authors:  David A Stevenson; Kyle Rudser; Alicia Kunin-Batson; Ellen B Fung; David Viskochil; Elsa Shapiro; Paul J Orchard; Chester B Whitley; Lynda E Polgreen
Journal:  J Pediatr Rehabil Med       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.